TVRD
Tvardi Therapeutics
TVRD
TVRD
126 hedge funds and large institutions have $559M invested in Tvardi Therapeutics in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 28 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less call options, than puts
Call options by funds: $20.9M | Put options by funds: $21.7M
7% less funds holding
Funds holding: 135 → 126 (-9)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
Holders
126
Holding in Top 10
3
Calls
$20.9M
Puts
$21.7M
Top Buyers
| 1 | +$20.6M | |
| 2 | +$20.5M | |
| 3 | +$20.5M | |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$12M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.73M |
Top Sellers
| 1 | -$6.45M | |
| 2 | -$5.96M | |
| 3 | -$3.92M | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$2.39M |
| 5 |
C
Chescapmanager
Baltimore,
Maryland
|
-$2.17M |